Pharmacoeconomic Evaluation Of Doxycycline And Tetracycline In The Treatment Of Chlamydial Implicated Non-Gonococcal Urethritis In A Tertiary Healthcare Institution In Nigeria
| Autor: | G. K. Osagbemi, B. O. Olayinka, A. Giwa, H. B. F. Giwa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2008 |
| Předmět: |
Doxycycline
medicine.medical_specialty business.industry Tetracycline General Chemical Engineering Non-gonococcal urethritis Cost-effectiveness analysis medicine.disease Surgery Pharmacoeconomics Economic evaluation Medicine Urethritis Pharmacoeconomics Cost effectiveness analysis Doxycycline Tetracycline Nongonocccal Urethritis business Intensive care medicine health care economics and organizations Health policy medicine.drug |
| Zdroj: | African Journal of Clinical and Experimental Microbiology; Vol 10, No 1 (2009); 38-46 |
| ISSN: | 1595-689X |
| Popis: | With depressing nature of economy in many countries such as Nigeria where per capita income is low, there is need for utmost consideration for cost containment measures. Objective: The objective of this study is to conduct pharmacoeconomic evaluation of two antichlamydial indicated non-gonococcal urethritis therapeutic options and to make recommendations for inclusion of economic evaluation of drug therapies in health policy formulations and decision making. Methods: Cost effectiveness analysis was carried out retrospectively for prescribed/dispensed antibacterials to out-patients with chlamydial implicated non-gonococcal urethritis among other infectious diseases, by examining out-patient case notes between 2005 and 2007 in Ahmadu Bello University Teaching Hospital, Zaria Nigeria. Results : The result shows that doxycycline costs N1.33/unit of effectiveness while tetracycline costs N2.77/unit of effectiveness in the treatment of chlamydial implicated non-gonococcal urethritis. Doxycycline is therefore more cost effective than tetracycline capsules. Subjecting the costs and effectiveness to sensitivity analysis did not change this conclusion. There is statistically significant difference in the effectiveness (outcome) of doxycycline (78.8%) and tetracycline (58.7%) ( x2 =9.4; p African Journal of Clinical and Experimental Microbiology Vol. 10 (1) 2009: pp. 35-46 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|